These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4215399)

  • 1. [Quantitative immunological determination of antithrombin III concentration during normal pregnancy and post partum (author's transl)].
    Tatra G; Gruber W; Breitenecker G
    Arch Gynakol; 1974; 217(2):127-30. PubMed ID: 4215399
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral contraceptives and low antithrombin-3 concentration.
    Fagerhol MK; Abildgaard U; Bergsjo P; Jacobsen JH
    Lancet; 1970 May; 1(7657):1175. PubMed ID: 4194500
    [No Abstract]   [Full Text] [Related]  

  • 3. [The change of antithrombin III activity of pregnant women and women on oral contraceptives (author's transl)].
    Ogura H; Miyaji K; Kinoshita T; Aoki N
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):232-7. PubMed ID: 578068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of various estrogen treatment schedules on antithrombin III levels.
    Ambrus JL; Ambrus CM; Lillie MA; Browne BJ; Hanson FW; Niswander K; Witul M; Jung OS; Bartfay-Szabo A
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):543-9. PubMed ID: 959656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin 3 depression and thrombin generation acceleration in women taking oral contraceptives.
    Von Kaulla E; Droegemueller W; Aoki N; Von Kaulla KN
    Am J Obstet Gynecol; 1971 Mar; 109(6):868-73. PubMed ID: 5552623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effects of estrogen on antithrombin III (author's transl)].
    Fujimaki M; Nagasawa H; Konishi S; Kato M; Fukutake K
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):227-31. PubMed ID: 196473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activated factor X-antithrombin III reaction rate: a measure of the increased thrombotic tendency induced by estrogen-containing oral contraceptives in rabbits.
    Gitel SN; Stephenson RC; Wessler S
    Haemostasis; 1978; 7(1):10-8. PubMed ID: 640489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin 3 concentration in women using low-dosage progestogen for contraception.
    Bergsjö P; Fagerhol MK; Abildgaard U
    Am J Obstet Gynecol; 1972 Apr; 112(7):938-40. PubMed ID: 4114468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Natural oestrogens and antithrombin-III levels.
    Greig HB; Notelowitz M
    Lancet; 1975 Feb; 1(7903):412-3. PubMed ID: 46578
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombin 3 and the estrogen content of combined estro-progestagen contraceptives.
    Conard J; Samama M; Salomon Y
    Lancet; 1972 Nov; 2(7787):1148-9. PubMed ID: 4117229
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombin inhibitors in women on oral contraceptives.
    Guagnellini E; Bertolini G; Cappelletti M; Colombo G
    Acta Haematol; 1981; 65(3):205-10. PubMed ID: 6165217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological assay of antithrombin (anthrombin III and alpha2-macroglobulin) (author's transl)].
    Meguro T; Yamada K; Shirahata A
    Rinsho Byori; 1975 Aug; 23(8):635-8. PubMed ID: 811830
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypertension due to hormonal contraceptives and estrogens (author's transl)].
    Oelkers W
    MMW Munch Med Wochenschr; 1978 Mar; 120(13):439-44. PubMed ID: 306034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antithrombin 3 changes in women using oral contraceptives].
    Conard J; Salomon Y; Samama M
    Pathol Biol (Paris); 1974 Jan; 22(1):77-80. PubMed ID: 4592416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombin III during pregnancy and puerperium (author's transl)].
    Torner C; Leroy B; Fouche F; Perles R
    Nouv Presse Med; 1979 Jan; 8(1):46. PubMed ID: 554062
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological dtermination of at. III (author's transl)].
    Brogioni M; Biancalani L; Albertazzi M
    Quad Sclavo Diagn; 1976 Sep; 12(3):288-94. PubMed ID: 1025592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in antithrombin 3 and plasminogen induced by oral contraceptives.
    Peterson RA; Krull PE; Finley P; Ettinger MG
    Am J Clin Pathol; 1970 Apr; 53(4):468-73. PubMed ID: 5444720
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of estrogens on postpartum hypercoagulability and antithrombin 3 activity.
    von Kaulla E; Droegemueller W; Aoki N; von Kaulla KN
    Am J Obstet Gynecol; 1972 Aug; 113(7):920-6. PubMed ID: 4635741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic predisposition associated with oral contraceptives.
    Zuck TF; Bergin JJ
    Obstet Gynecol; 1973 Mar; 41(3):427-35. PubMed ID: 4688259
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural estrogen and anti-thrombin III activity in postmenopausal women.
    Notelovitz M; Greig HB
    J Reprod Med; 1976 Feb; 16(2):87-90. PubMed ID: 176358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.